Germany Breast Cancer Diagnostics And Therapeutics Market Trends, Size, Competitive Analysis And Forecast - 2019-2025


Germany Breast Cancer Diagnostics and Therapeutics Market Trends, Size, Competitive Analysis and Forecast - 2019-2025

Germany breast cancer diagnostics and therapeutics market are estimated to grow significantly at a CAGR of 9.3% during the forecast period. Increasing the incidence of breast cancer coupled with a growing awareness program towrds breast cancer diagnosis and treatment are the major factors that contributing to the growth of the market. According to the WHO, in 2018 there were 71,888 new cases of breast cancer in Germany. The growing cases of breast cancer in the country further propels thed demand for diagnostics and further treatment facilities for breast cancer thus contributing to the market growth. The statutory early detection program offers women above 30 years of age an annual palpation examination by a physician. According to the quality assured Mammography Screening Program in Germany, and women between 50 and 69 years of age are invited to an X-ray examination of the breasts every two years. 

Request a free sample of our report on Germany Breast Cancer Diagnostics and Therapeutics Market:

Germany breast cancer diagnosis and therapeutics market are segmented on the basis of cancer type, diagnostics, and therapeutics. In cancer type segment market is further classified into ductal carcinoma in-situ (DCIS), invasive ductal carcinoma (IDC), triple negative breast cancer (TNBC), inflammatory breast cancer and others. In diagnostics technology, the segment market is further classified into mammography, biopsy, position emission tomography/computed tomography, ultrasound, and others. The therapeutics technology segment market is further segregated into chemotherapy, hormone therapy, targeted therapy, and others. 

A full report of Germany Breast Cancer Diagnostics and Therapeutics Market is available at:

Germany Breast Cancer Diagnostics and Therapeutics Market Segmentation

By Cancer Type

  • Ductal Carcinoma In-Situ (DCIS)
  • Invasive Ductal Carcinoma (IDC) 
  • Triple Negative Breast Cancer (TNBC)
  • Inflammatory Breast Cancer
  • Others (Invasive lobular carcinoma) 

By Diagnostics

  • Mammography
  • Biopsy
  • Ultrasound
  • Others (MRI)

By Therapeutics

  • Chemotherapy
  • Hormone Therapy
  • Targeted Therapy
  • Others (Radiation Therapy, Surgery)

Company Profiles

  • Agendia NV
  • AstraZeneca PLC
  • Bayer AG
  • GlaxoSmithKline PLC
  • Mylan NV
  • Merck & Co., Inc.
  • Novartis International AG
  • F. Hoffmann-La Roche AG
  • Sanofi S.A.
  • Siemens Healthcare GmbH

For more customized data, request for report customization @

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.


For More Information, Visit

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari


Contact no: +1 646-755-7667, +91 780-304-0404



Keywords: size,share,industry growth,future prospects,opportunities,forecast 2019-2025


Other related blogs

Cappuccino MCT Weight Loss

By : Cappuccino MCT

A large number of my patients go to their first meeting with an unmistakable "non-debatable:" "I'm h..

Expect COVID-19 vaccine in 2021 – GHS hints

By : Ghana Talks Radio

  Director General of the Ghana Health Service, Dr. Patrick Kuma-Aboagye says vaccine to tre..

7 Moments To Remember From Melt Stress Away With A Soothing Massage

By : Dubai.Riverdayspa

The pervasive pressure affects 7-year-old to 70-year-old in any form or the other. Among the rush of..

Neuro Touch Therapy – Mobile Massage Therapy

By : Digital Market

Intended to furnish proficient portable back rub treatment administrations with occupied ways of lif..